TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170,263 | +5.2% | 11,006 | +6.8% | 0.05% | +11.6% |
| Q2 2023 | $161,829 | +55.8% | 10,301 | +63.5% | 0.04% | +48.3% |
| Q1 2023 | $103,857 | +16.6% | 6,302 | +10.3% | 0.03% | +16.0% |
| Q4 2022 | $89,092 | +20.4% | 5,711 | -0.2% | 0.02% | 0.0% |
| Q3 2022 | $74,000 | -7.5% | 5,722 | 0.0% | 0.02% | -3.8% |
| Q2 2022 | $80,000 | +207.7% | 5,722 | +292.5% | 0.03% | +188.9% |
| Q3 2020 | $26,000 | -7.1% | 1,458 | 0.0% | 0.01% | -10.0% |
| Q2 2020 | $28,000 | +21.7% | 1,458 | -5.6% | 0.01% | 0.0% |
| Q1 2020 | $23,000 | -20.7% | 1,544 | +5.2% | 0.01% | -9.1% |
| Q4 2019 | $29,000 | +11.5% | 1,467 | -1.1% | 0.01% | +10.0% |
| Q3 2019 | $26,000 | +4.0% | 1,484 | +6.2% | 0.01% | 0.0% |
| Q2 2019 | $25,000 | -10.7% | 1,398 | 0.0% | 0.01% | -9.1% |
| Q1 2019 | $28,000 | – | 1,398 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |